Enslein K - Search Results

1

Zeiger E, Ashby J, Bakale G, Enslein K, Klopman G, Rosenkranz HS. Zeiger E, et al. Among authors: enslein k. Mutagenesis. 1996 Sep;11(5):471-84. doi: 10.1093/mutage/11.5.471. Mutagenesis. 1996. PMID: 8921509

2

Prediction of probability of carcinogenicity for a set of ongoing NTP bioassays.

Enslein K, Blake BW, Borgstedt HH. Enslein K, et al. Mutagenesis. 1990 Jul;5(4):305-6. doi: 10.1093/mutage/5.4.305. Mutagenesis. 1990. PMID: 2398815

3

Mutagenicity (Ames): a structure-activity model.

Enslein K, Lander TR, Tomb ME, Landis WG. Enslein K, et al. Teratog Carcinog Mutagen. 1983;3(6):503-13. doi: 10.1002/1520-6866(1990)3:6<503::aid-tcm1770030606>3.0.co;2-o. Teratog Carcinog Mutagen. 1983. PMID: 6140769

4

Salmonella mutagenicity and rodent carcinogenicity: quantitative structure-activity relationships.

Blake BW, Enslein K, Gombar VK, Borgstedt HH. Blake BW, et al. Among authors: enslein k. Mutat Res. 1990 Jul;241(3):261-71. doi: 10.1016/0165-1218(90)90023-u. Mutat Res. 1990. PMID: 2195334

5

Assessment of effect levels of chemicals from quantitative structure-activity relationship (QSAR) models. I. Chronic lowest-observed-adverse-effect level (LOAEL).

Mumtaz MM, Knauf LA, Reisman DJ, Peirano WB, DeRosa CT, Gombar VK, Enslein K, Carter JR, Blake BW, Huque KI, et al. Mumtaz MM, et al. Among authors: enslein k. Toxicol Lett. 1995 Sep;79(1-3):131-43. doi: 10.1016/0378-4274(95)03365-r. Toxicol Lett. 1995. PMID: 7570650

6

An overview of structure-activity relationships as an alternative to testing in animals for carcinogenicity, mutagenicity, dermal and eye irritation, and acute oral toxicity.

Enslein K. Enslein K. Toxicol Ind Health. 1988 Dec;4(4):479-98. doi: 10.1177/074823378800400407. Toxicol Ind Health. 1988. PMID: 3188045

7

International Commission for Protection Against Environmental Mutagens and Carcinogens. Use of SAR in computer-assisted prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program.

Enslein K, Gombar VK, Blake BW. Enslein K, et al. Mutat Res. 1994 Feb 1;305(1):47-61. doi: 10.1016/0027-5107(94)90125-2. Mutat Res. 1994. PMID: 7508547 Review. No abstract available.

8

Teratogenesis: a statistical structure-activity model.

Enslein K, Lander TR, Strange JR. Enslein K, et al. Teratog Carcinog Mutagen. 1983;3(3):289-309. doi: 10.1002/1520-6866(1990)3:3<289::aid-tcm1770030308>3.0.co;2-3. Teratog Carcinog Mutagen. 1983. PMID: 6137085

9

A predictive model for estimating rat oral LD50 values.

Enslein K, Lander TR, Tomb ME, Craig PN. Enslein K, et al. Toxicol Ind Health. 1989 Mar;5(2):261-387. doi: 10.1177/074823378900500210. Toxicol Ind Health. 1989. PMID: 2728019 No abstract available.

10

A QSAR model for the estimation of carcinogenicity: example application to an azo-dye.

Enslein K, Borgstedt HH. Enslein K, et al. Toxicol Lett. 1989 Dec;49(2-3):107-21. doi: 10.1016/0378-4274(89)90027-1. Toxicol Lett. 1989. PMID: 2603166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters